Mark Froimowitz

1.5k total citations
54 papers, 1.2k citations indexed

About

Mark Froimowitz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Spectroscopy. According to data from OpenAlex, Mark Froimowitz has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 25 papers in Cellular and Molecular Neuroscience and 18 papers in Spectroscopy. Recurrent topics in Mark Froimowitz's work include Receptor Mechanisms and Signaling (14 papers), Analytical Chemistry and Chromatography (13 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Mark Froimowitz is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Analytical Chemistry and Chromatography (13 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Mark Froimowitz collaborates with scholars based in United States and Israel. Mark Froimowitz's co-authors include Vivian Cody, Clifford George, Solomon H. Snyder, Jeffrey T. Ehmsen, Alo C. Basu, Joseph T. Coyle, Richard Bergeron, Asif K. Mustafa, Michael A. Benneyworth and Nicholas Lange and has published in prestigious journals such as Journal of the American Chemical Society, Macromolecules and Journal of Computational Physics.

In The Last Decade

Mark Froimowitz

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Froimowitz United States 16 644 462 296 231 178 54 1.2k
Howard B. Broughton United States 27 1.2k 1.9× 461 1.0× 899 3.0× 128 0.6× 159 0.9× 92 2.4k
Jean‐Jacques Bourguignon France 22 657 1.0× 419 0.9× 799 2.7× 46 0.2× 91 0.5× 83 1.7k
Erik Falch Denmark 23 841 1.3× 712 1.5× 365 1.2× 54 0.2× 141 0.8× 54 1.5k
Robert A. Volkmann United States 23 1.1k 1.7× 385 0.8× 367 1.2× 112 0.5× 113 0.6× 45 1.7k
Saı̈d Yous France 23 812 1.3× 216 0.5× 844 2.9× 61 0.3× 205 1.2× 111 2.0k
Walter Weyler United States 23 979 1.5× 361 0.8× 296 1.0× 214 0.9× 39 0.2× 42 1.9k
Emmanuel Pinard Switzerland 20 545 0.8× 321 0.7× 385 1.3× 141 0.6× 38 0.2× 44 1.3k
Santiago Vázquez Spain 26 849 1.3× 118 0.3× 737 2.5× 224 1.0× 93 0.5× 128 2.2k
Anette M. Johansson Sweden 25 938 1.5× 695 1.5× 388 1.3× 74 0.3× 81 0.5× 62 1.6k
Jacob Andersen Denmark 21 971 1.5× 804 1.7× 327 1.1× 100 0.4× 135 0.8× 42 1.8k

Countries citing papers authored by Mark Froimowitz

Since Specialization
Citations

This map shows the geographic impact of Mark Froimowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Froimowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Froimowitz more than expected).

Fields of papers citing papers by Mark Froimowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Froimowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Froimowitz. The network helps show where Mark Froimowitz may publish in the future.

Co-authorship network of co-authors of Mark Froimowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Froimowitz. A scholar is included among the top collaborators of Mark Froimowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Froimowitz. Mark Froimowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xi, Zheng‐Xiong, Rui Song, Xia Li, et al.. (2016). CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction. Neuropsychopharmacology. 42(3). 682–694. 13 indexed citations
3.
Basu, Alo C., Jeffrey T. Ehmsen, Asif K. Mustafa, et al.. (2008). Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Molecular Psychiatry. 14(7). 719–727. 264 indexed citations
4.
Froimowitz, Mark, et al.. (2005). Vinylogous amide analogs of methylphenidate. Bioorganic & Medicinal Chemistry Letters. 15(12). 3044–3047. 13 indexed citations
5.
Froimowitz, Mark, et al.. (2000). Conformational preferences of the potent dopamine reuptake blocker BTCP and its analogs and their incorporation into a pharmacophore model. Journal of Computer-Aided Molecular Design. 14(2). 135–146. 10 indexed citations
6.
Froimowitz, Mark, et al.. (2000). Slow-Onset, Long-Duration 3-(3‘,4‘-Dichlorophenyl)-1-indanamine Monoamine Reuptake Blockers as Potential Medications To Treat Cocaine Abuse. Journal of Medicinal Chemistry. 43(26). 4981–4992. 82 indexed citations
7.
Teeter, Martha M., Mark Froimowitz, Boguslaw Stec, & Curtiss J. DuRand. (1994). Homology Modeling of the Dopamine D2 Receptor and Its Testing by Docking of Agonists and Tricyclic Antagonists. Journal of Medicinal Chemistry. 37(18). 2874–2888. 71 indexed citations
8.
Yin, Dali, Atmaram D. Khanolkar, Alexandros Makriyannis, & Mark Froimowitz. (1994). Chiral resolution of 1,3-dimethyl-4-phenylpiperidine derivatives using high-performance liquid chromatography with a chiral stationary phase. Journal of Chromatography A. 678(1). 176–179. 8 indexed citations
9.
Froimowitz, Mark & Vivian Cody. (1993). Biologically active conformers of phenothiazines and thioxanthenes. Further evidence for a ligand model of dopamine D2 receptor antagonists. Journal of Medicinal Chemistry. 36(15). 2219–2227. 21 indexed citations
10.
Froimowitz, Mark & Vivian Cody. (1993). Enantiomeric conformers of the opioid agonist ketobemidone HCl in the crystal state. Chirality. 5(7). 560–564. 1 indexed citations
11.
12.
Froimowitz, Mark, Chaim G. Pick, & Gavril W. Pasternak. (1992). Phenylmorphans and analogs: opioid receptor subtype selectivity and effect of conformation on activity. Journal of Medicinal Chemistry. 35(9). 1521–1525. 9 indexed citations
13.
Froimowitz, Mark, Walter Pangborn, & Vivian Cody. (1992). Absolute configuration and conformation of the pure opioid antagonist (+)‐2,9α‐dimethyl‐5‐(m‐hydroxyphenyl)morphan. Chirality. 4(6). 377–383. 3 indexed citations
14.
Froimowitz, Mark, et al.. (1991). Conformational properties of semirigid antipsychotic drugs: the pharmacophore for dopamine D2 antagonist activity. Journal of Medicinal Chemistry. 34(5). 1707–1714. 14 indexed citations
15.
Froimowitz, Mark. (1990). Conformational search in enkephalin analogues containing a disulfide bond. Biopolymers. 30(11-12). 1011–1025. 23 indexed citations
16.
Leli, Ubaldo, George Hauser, & Mark Froimowitz. (1990). Requirements for the activation of protein kinase C: comparison of the molecular geometries of phorbol and diacylglycerol.. Molecular Pharmacology. 37(2). 286–295. 10 indexed citations
17.
Froimowitz, Mark & Victor J. Hruby. (1989). Conformational analysis of enkephalin analogs contaIntng a disulfide bond Models for delta‐ and mu‐receptor opioid agonists. International journal of peptide & protein research. 34(2). 88–96. 32 indexed citations
18.
Svendsen, Clive N., Mark Froimowitz, Alexander Campbell, et al.. (1988). Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: Evidence for different stereoselectivities at D1 and D2 receptors in rat brain. Neuropharmacology. 27(11). 1117–1124. 34 indexed citations
19.
Froimowitz, Mark, et al.. (1987). A Stereochemical and Conformational Model of Dopaminergic Agonist and Antagonist Activity: Further Evaluation. Journal of Pharmaceutical Sciences. 76(7). 557–564. 9 indexed citations
20.
Froimowitz, Mark & Steven Matthysse. (1983). Conformational properties of butaclamol and isobutaclamol. Regularities in the structures of semirigid neuroleptics.. Molecular Pharmacology. 24(2). 243–250. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Howard B. Broughton Breakdown of academic impact, for papers by Jean‐Jacques Bourguignon Breakdown of academic impact, for papers by Erik Falch Breakdown of academic impact, for papers by Robert A. Volkmann Breakdown of academic impact, for papers by Saı̈d Yous Breakdown of academic impact, for papers by Walter Weyler Breakdown of academic impact, for papers by Emmanuel Pinard Breakdown of academic impact, for papers by Santiago Vázquez Breakdown of academic impact, for papers by Anette M. Johansson Breakdown of academic impact, for papers by Jacob Andersen
Rankless by CCL
2026